Alpha Cognition Inc Share Price

NASDAQ: ACOG

Small Cap

$8.16

-0.56

(-6.42%)

as on September 18, 2025 at 1:29 am IST

$₹

Alpha Cognition Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$8.15
Day's Price Range
$9.6
$8.16
0.12%
Downside
17.65%
Upside
52 Week's Low
52 Week's High
$3.75
52-Week Price Range
$11.54
$8.16
54.04%
Downside
41.42%
Upside

Alpha Cognition Inc share price movements today

Previous Close: $8.72
Open: $8.88
Volume: 160.7K
Day's Low - High: $8.15 - $9.6
52 Week Low - High: $3.75 - $11.54

Alpha Cognition Inc Historical Returns

1 Month Return: + 11.9 %
3 Month Return: + 5.76 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Alpha Cognition Inc Stock Fundamentals & Key Indicators

Check Alpha Cognition Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$160.2M

EPS (TTM)

-1.47

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

1089000.00%

Alpha Cognition Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alpha Cognition Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Alpha Cognition Inc	NA	$160.2M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	248.74%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Alpha Cognition Inc Stock's Interest Amongst Investors

Search interest for Alpha Cognition Inc Stock has decreased by -26% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-26% versus previous 30 day period

Alpha Cognition Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	2	1
Gross Profit	-	-	-	-	0	0	2	1
Operating Income	-2	-2	-4	-2	-1	-2	-3	-5
EBITDA	-3	-5	-4	-2	-1	-5	-1	-5
Interest Expense	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0
Income Before Tax	-3	-5	-4	-2	-1	-5	-2	-10
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-3	-5	-4	-2	-1	-5	-2	-10
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-68.51%	-632.75%

Alpha Cognition Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	0
Operating Income	-5	-11	-13	-9	-11
EBITDA	-4	-18	-11	-13	-14
Interest Expense	0	0	0	0	0
Depreciation	0	0	0	0	0
Income Before Tax	-5	-19	-12	-13	-14
Income Tax Expense	-	-	-	-	-
Net Income	-5	-19	-12	-13	-14
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Alpha Cognition Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-2	-3	-5	-5	-2	-1	-5	-2	-10
Operating Cash Flow	-2	-1	-2	-2	-1	-1	-2	-2	-6
Investing Cash Flow	-	-	-	-	-	-	0	0	0
Financing Cash Flow	0	1	2	3	0	4	47	0	0
Change in Cash	-2	0	0	0	-1	2	44	-2	-6

Alpha Cognition Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-19	-12	-13	-14
Operating Cash Flow	-9	-9	-8	-7
Investing Cash Flow	0	0	-	0
Financing Cash Flow	14	0	8	54
Change in Cash	5	-9	0	47

Insights on Alpha Cognition Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, ACOG stock has moved down by -13.4%

About Alpha Cognition Inc

Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company's ZUNVEYL (benzgalantamine) product is a delayed release oral tablet formulation indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults. Its pre-clinical development programs include ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mTBI; ALPHA-0602; ALPHA-0702 & ALPHA-0802 (Progranulin and Progranulin GEM’s) for the treatment of neurodegenerative diseases including amyotrophic lateral sclerosis or Lou Gehrig’s disease and spinal muscular atrophy, and ALPHA-1062 for the treatment of acute pancreatitis.

Organisation	Alpha Cognition Inc
Headquarters	750 West Pender Street, Vancouver, BC, Canada, V6C 2T8
CEO	Mr. Michael E. McFadden B.B.A.
E-voting on shares	Click here to vote

Key Management of Alpha Cognition Inc

Name	Title
Dr. Denis G. Kay M.Sc., Ph.D.	Chief Scientific Officer
Mr. Timothy Ayers	Head of Compliance
Ms. Amy Kincaid	Executive Director, Head of Marketing & Commercial Strategy
Mr. Jack Kelly	Executive Director & Head of Market Access
Mr. Michael E. McFadden B.B.A.	CEO & Director
Ms. Lauren D'Angelo M.B.A.	Chief Operating Officer
Mr. Kenneth Anthony Cawkell B.A., LL.B.	Founder, Consultant, Corporate Secretary & Director
Mr. Henry Du CPA	VP of Finance & Accounting and Interim CFO

FAQs

What is Alpha Cognition Inc share price today?

Alpha Cognition Inc share price today is $8.16 as on September 18, 2025 at 1:29 am IST at the close of the market. Alpha Cognition Inc share today touched a day high of $9.6 and a low of $8.15.

What is the 52 week high and 52 week low for Alpha Cognition Inc share?

Alpha Cognition Inc share touched a 52 week high of $11.54 on July 10, 2025 and a 52 week low of $3.75 on April 8, 2025. Alpha Cognition Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $8.16,which is 29.29% down from its 52 week high and 117.60% up from its 52 week low.

What is Alpha Cognition Inc's market capitalisation today?

Alpha Cognition Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Alpha Cognition Inc Stock (ACOG) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Alpha Cognition Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alpha Cognition Inc Shares that will get you 0.1838 shares as per Alpha Cognition Inc share price of $8.16 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Alpha Cognition Inc Stock (ACOG) from India?

Indian investors can start investing in Alpha Cognition Inc (ACOG) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 4:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Alpha Cognition Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 4:43 pm IST). Based on Alpha Cognition Inc share’s latest price of $8.16 as on September 18, 2025 at 1:29 am IST, you will get 1.2255 shares of Alpha Cognition Inc. Learn more about fractional shares .